Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,8378 USD | +4,09% | +1,92% | -11,57% |
Vakgebied
Aantal werknemers: 58
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Immune-mediated Diseases and Cancer Therapeutics
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 19-02-15 |
John Fowler
FOU | Founder | 52 | 19-02-15 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 01-03-18 |
Gitanjali Jain
IRC | Investor Relations Contact | - | 05-10-21 |
Nick Mordwinkin
PRN | Corporate Officer/Principal | - | 11-07-22 |
Li Long
PRN | Corporate Officer/Principal | - | - |
Andrea Fan
PRN | Corporate Officer/Principal | - | 01-01-15 |
Jinhai Wang
PRN | Corporate Officer/Principal | - | - |
General Counsel | - | - | |
General Counsel | - | 01-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 01-11-16 |
Graham Cooper
CHM | Chairman | 54 | 01-10-17 |
Michael Kauffman
BRD | Director/Board Member | 60 | 01-12-16 |
John Fowler
FOU | Founder | 52 | 19-02-15 |
Christopher Kirk
FOU | Founder | 52 | 19-02-15 |
Elizabeth Garner
BRD | Director/Board Member | 56 | 18-12-19 |
Courtney Wallace
BRD | Director/Board Member | 40 | 09-12-21 |
Micki Klearman
BRD | Director/Board Member | 69 | 01-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 72 801 359 | 62 021 528 ( 85,19 %) | 0 | 85,19 % |
Bedrijfsgegevens
Kezar Life Sciences, Inc.
4000 Shoreline Court Suite 300
94080, South San Francisco
+650 822 5600
http://www.kezarlifesciences.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,57% | 60,99 mln. | |
-2,63% | 102 mld. | |
+1,62% | 96,29 mld. | |
+1,95% | 22,18 mld. | |
-16,67% | 21,2 mld. | |
-9,10% | 18,31 mld. | |
-38,74% | 17,38 mld. | |
-13,21% | 16,36 mld. | |
+5,41% | 13,97 mld. | |
+33,57% | 12,17 mld. |